000			01938 a2200553 4500
005			20250516004358.0
264		0	_c20110307
008			201103s 0 0 eng d
022			_a1029-2403
024	7		_a10.3109/10428194.2010.522285 _2doi
040			_aNLM _beng _cNLM
100	1		_aHanzawa, Kyoko
245	0	0	_aY-box binding protein-1 expression in diffuse large B-cell lymphoma: an impact on prognosis in the rituximab era. _h[electronic resource]
260			_bLeukemia & lymphoma _cNov 2010
300			_a2054-62 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBiomarkers, Pharmacological _xmetabolism
650	0	4	_aBiomarkers, Tumor _xmetabolism
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aDoxorubicin _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLymphoma, Large B-Cell, Diffuse _xdiagnosis
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrednisone _xtherapeutic use
650	0	4	_aPrognosis
650	0	4	_aRituximab
650	0	4	_aSurvival Analysis
650	0	4	_aVincristine _xtherapeutic use
650	0	4	_aY-Box-Binding Protein 1 _xmetabolism
700	1		_aMomose, Shuji
700	1		_aHigashi, Morihiro
700	1		_aTokuhira, Michihide
700	1		_aWatanabe, Reiko
700	1		_aKajino, Kazunori
700	1		_aHino, Okio
700	1		_aItoyama, Shinji
700	1		_aKizaki, Masahiro
700	1		_aTamaru, Jun-ichi
773	0		_tLeukemia & lymphoma _gvol. 51 _gno. 11 _gp. 2054-62
856	4	0	_uhttps://doi.org/10.3109/10428194.2010.522285 _zAvailable from publisher's website
999			_c20234031 _d20234031